{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T10:35:11Z","timestamp":1779878111659,"version":"3.53.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,5,29]],"date-time":"2014-05-29T00:00:00Z","timestamp":1401321600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s12282-014-0542-2","type":"journal-article","created":{"date-parts":[[2014,5,28]],"date-time":"2014-05-28T07:06:16Z","timestamp":1401260776000},"page":"141-148","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Clinical significance of FDG-PET\/CT at the postoperative surveillance in the breast cancer patients"],"prefix":"10.1007","volume":"23","author":[{"given":"Na Young","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ie Ryung","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bong Joo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Hun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byung Joo","family":"Chae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye Young","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,5,29]]},"reference":[{"issue":"2","key":"542_CR1","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1053\/j.semnuclmed.2004.11.001","volume":"35","author":"WB Eubank","year":"2005","unstructured":"Eubank WB, Mankoff DA. Evolving role of positron emission tomography in breast cancer imaging. Semin Nucl Med. 2005;35(2):84\u201399.","journal-title":"Semin Nucl Med"},{"issue":"20","key":"542_CR2","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1200\/JCO.2000.18.20.3495","volume":"18","author":"N Avril","year":"2000","unstructured":"Avril N, Rose CA, Schelling M, Dose J, Kuhn W, Bense S, et al. Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations. J Clin Oncol. 2000;18(20):3495\u2013502.","journal-title":"J Clin Oncol"},{"issue":"15","key":"542_CR3","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1200\/JCO.2008.19.8424","volume":"27","author":"SJ Anderson","year":"2009","unstructured":"Anderson SJ, Wapnir I, Dignam JJ, Fisher B, Mamounas EP, Jeong JH, et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer. J Clin Oncol. 2009;27(15):2466\u201373.","journal-title":"J Clin Oncol"},{"issue":"13","key":"542_CR4","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1200\/JCO.2005.04.3273","volume":"24","author":"IL Wapnir","year":"2006","unstructured":"Wapnir IL, Anderson SJ, Mamounas EP, Geyer CE Jr, Jeong JH, Tan-Chiu E, et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials. J Clin Oncol. 2006;24(13):2028\u201337.","journal-title":"J Clin Oncol"},{"issue":"7","key":"542_CR5","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s002680020095","volume":"25","author":"TS Kim","year":"2001","unstructured":"Kim TS, Moon WK, Lee DS, Chung JK, Lee MC, Youn YK, et al. Fluorodeoxyglucose positron emission tomography for detection of recurrent or metastatic breast cancer. World J Surg. 2001;25(7):829\u201334.","journal-title":"World J Surg"},{"issue":"2","key":"542_CR6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1148\/rg.232025705","volume":"23","author":"L Kostakoglu","year":"2003","unstructured":"Kostakoglu L, Agress H, Jr, Goldsmith SJ. Clinical role of FDG PET in evaluation of cancer patients. Radiographics. 2003;23(2):315\u201340 quiz 533.","journal-title":"Radiographics"},{"issue":"5","key":"542_CR7","first-page":"816","volume":"41","author":"KH Bohuslavizki","year":"2000","unstructured":"Bohuslavizki KH, Klutmann S, Kroger S, Sonnemann U, Buchert R, Werner JA, et al. FDG PET detection of unknown primary tumors. J Nucl Med. 2000;41(5):816\u201322.","journal-title":"J Nucl Med"},{"issue":"3","key":"542_CR8","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1053\/snuc.2000.7439","volume":"30","author":"R Bar-Shalom","year":"2000","unstructured":"Bar-Shalom R, Valdivia AY, Blaufox MD. PET imaging in oncology. Semin Nucl Med. 2000;30(3):150\u201385.","journal-title":"Semin Nucl Med"},{"issue":"5","key":"542_CR9","first-page":"250","volume":"38","author":"HJ Gallowitsch","year":"2003","unstructured":"Gallowitsch HJ, Kresnik E, Gasser J, Kumnig G, Igerc I, Mikosch P, et al. F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging. Invest Radiol. 2003;38(5):250\u20136.","journal-title":"Invest Radiol"},{"key":"542_CR10","doi-asserted-by":"crossref","unstructured":"Litmanovich D, Gourevich K, Israel O, Gallimidi Z. Unexpected foci of (18)F-FDG uptake in the breast detected by PET\/CT: incidence and clinical significance. Eur J Nucl Med Mol Imaging. 2009.","DOI":"10.1007\/s00259-009-1147-4"},{"issue":"3","key":"542_CR11","first-page":"325","volume":"43","author":"D Vranjesevic","year":"2002","unstructured":"Vranjesevic D, Filmont JE, Meta J, Silverman DH, Phelps ME, Rao J, et al. Whole-body (18)F-FDG PET and conventional imaging for predicting outcome in previously treated breast cancer patients. J Nucl Med. 2002;43(3):325\u20139.","journal-title":"J Nucl Med"},{"issue":"955","key":"542_CR12","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1259\/bjr\/17395663","volume":"80","author":"P Veit-Haibach","year":"2007","unstructured":"Veit-Haibach P, Antoch G, Beyer T, Stergar H, Schleucher R, Hauth EA, et al. FDG-PET\/CT in restaging of patients with recurrent breast cancer: possible impact on staging and therapy. Br J Radiol. 2007;80(955):508\u201315.","journal-title":"Br J Radiol"},{"issue":"4","key":"542_CR13","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.2214\/ajr.184.4.01841266","volume":"184","author":"T Uematsu","year":"2005","unstructured":"Uematsu T, Yuen S, Yukisawa S, Aramaki T, Morimoto N, Endo M, et al. Comparison of FDG PET and SPECT for detection of bone metastases in breast cancer. AJR Am J Roentgenol. 2005;184(4):1266\u201373.","journal-title":"AJR Am J Roentgenol"},{"issue":"8","key":"542_CR14","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/00006231-200108000-00005","volume":"22","author":"M Ohta","year":"2001","unstructured":"Ohta M, Tokuda Y, Suzuki Y, Kubota M, Makuuchi H, Tajima T, et al. Whole body PET for the evaluation of bony metastases in patients with breast cancer: comparison with 99Tcm-MDP bone scintigraphy. Nucl Med Commun. 2001;22(8):875\u20139.","journal-title":"Nucl Med Commun"},{"issue":"11","key":"542_CR15","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s00259-005-1842-8","volume":"32","author":"T Nakai","year":"2005","unstructured":"Nakai T, Okuyama C, Kubota T, Yamada K, Ushijima Y, Taniike K, et al. Pitfalls of FDG-PET for the diagnosis of osteoblastic bone metastases in patients with breast cancer. Eur J Nucl Med Mol Imaging. 2005;32(11):1253\u20138.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"542_CR16","first-page":"15","volume":"48","author":"J Hyun","year":"2007","unstructured":"Hyun J, Yoo IR, Kim SH, Sohn HS, Chung SK. Clinical significance of small pulmonary nodules with little or no 18F-FDG uptake on PET\/CT images of patients with nonthoracic malignancies. J Nucl Med. 2007;48(1):15\u201321.","journal-title":"J Nucl Med"},{"issue":"5","key":"542_CR17","first-page":"752","volume":"46","author":"T Ishimori","year":"2005","unstructured":"Ishimori T, Patel PV, Wahl RL. Detection of unexpected additional primary malignancies with PET\/CT. J Nucl Med. 2005;46(5):752\u20137.","journal-title":"J Nucl Med"},{"issue":"2","key":"542_CR18","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.breast.2011.10.005","volume":"21","author":"ME Brennan","year":"2012","unstructured":"Brennan ME, Houssami N. Evaluation of the evidence on staging imaging for detection of asymptomatic distant metastases in newly diagnosed breast cancer. Breast. 2012;21(2):112\u201323.","journal-title":"Breast"},{"issue":"2","key":"542_CR19","doi-asserted-by":"crossref","first-page":"136","DOI":"10.6004\/jnccn.2011.0016","volume":"9","author":"RW Carlson","year":"2011","unstructured":"Carlson RW, Allred DC, Anderson BO, Burstein HJ, Carter WB, Edge SB, et al. Invasive breast cancer. J Natl Compr Canc Netw. 2011;9(2):136\u2013222.","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"542_CR20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejso.2011.09.002","volume":"38","author":"Z Garami","year":"2012","unstructured":"Garami Z, Hascsi Z, Varga J, Dinya T, Tanyi M, Garai I, et al. The value of 18-FDG PET\/CT in early-stage breast cancer compared to traditional diagnostic modalities with an emphasis on changes in disease stage designation and treatment plan. Eur J Surg Oncol. 2012;38(1):31\u20137.","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"542_CR21","doi-asserted-by":"crossref","first-page":"738","DOI":"10.2967\/jnumed.108.061416","volume":"50","author":"JH Lee","year":"2009","unstructured":"Lee JH, Rosen EL, Mankoff DA. The role of radiotracer imaging in the diagnosis and management of patients with breast cancer: part 2\u2013response to therapy, other indications, and future directions. J Nucl Med. 2009;50(5):738\u201348.","journal-title":"J Nucl Med"},{"issue":"1","key":"542_CR22","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10549-010-0771-9","volume":"123","author":"R Peare","year":"2010","unstructured":"Peare R, Staff RT, Heys SD. The use of FDG-PET in assessing axillary lymph node status in breast cancer: a systematic review and meta-analysis of the literature. Breast Cancer Res Treat. 2010;123(1):281\u201390.","journal-title":"Breast Cancer Res Treat"},{"issue":"12","key":"542_CR23","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1200\/JCO.2011.40.6975","volume":"30","author":"DA Mankoff","year":"2012","unstructured":"Mankoff DA, Specht JM, Eubank WB, Kessler L. [(1)(8)F]fluorodeoxyglucose positron emission tomography-computed tomography in breast cancer: when\u2026 and when not? J Clin Oncol. 2012;30(12):1252\u20134.","journal-title":"J Clin Oncol"}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-014-0542-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12282-014-0542-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-014-0542-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T16:40:56Z","timestamp":1559580056000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12282-014-0542-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,29]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["542"],"URL":"https:\/\/doi.org\/10.1007\/s12282-014-0542-2","relation":{},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"value":"1340-6868","type":"print"},{"value":"1880-4233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,29]]}}}